Nothing Special   »   [go: up one dir, main page]

DE69520041D1 - Arzneimittel auf der basis von einer synergistischen mischung von metronidazol und clinamicin - Google Patents

Arzneimittel auf der basis von einer synergistischen mischung von metronidazol und clinamicin

Info

Publication number
DE69520041D1
DE69520041D1 DE69520041T DE69520041T DE69520041D1 DE 69520041 D1 DE69520041 D1 DE 69520041D1 DE 69520041 T DE69520041 T DE 69520041T DE 69520041 T DE69520041 T DE 69520041T DE 69520041 D1 DE69520041 D1 DE 69520041D1
Authority
DE
Germany
Prior art keywords
clinamicin
metronidazole
products based
medicinal products
synergistic mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69520041T
Other languages
English (en)
Other versions
DE69520041T2 (de
Inventor
Janusz Czernielewski
Josiane Allec
Martine Bouclier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Application granted granted Critical
Publication of DE69520041D1 publication Critical patent/DE69520041D1/de
Publication of DE69520041T2 publication Critical patent/DE69520041T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE69520041T 1994-07-06 1995-06-20 Arzneimittel auf der basis von einer synergistischen mischung von metronidazol und clinamicin Expired - Lifetime DE69520041T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9408350A FR2722098B1 (fr) 1994-07-06 1994-07-06 Nouveaux medicaments a base de metro-nidazole ou d'un melange synergetique de metronidazole et de clindamycine
PCT/FR1995/000819 WO1996001117A1 (fr) 1994-07-06 1995-06-20 Medicaments a base de metronidazole ou d'un melange synergetique de metronidazole et de clindamycine

Publications (2)

Publication Number Publication Date
DE69520041D1 true DE69520041D1 (de) 2001-03-08
DE69520041T2 DE69520041T2 (de) 2001-06-21

Family

ID=9465069

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69520041T Expired - Lifetime DE69520041T2 (de) 1994-07-06 1995-06-20 Arzneimittel auf der basis von einer synergistischen mischung von metronidazol und clinamicin

Country Status (11)

Country Link
US (1) US5849776A (de)
EP (1) EP0768884B1 (de)
JP (1) JP3006888B2 (de)
AU (1) AU2798495A (de)
CA (1) CA2191129C (de)
DE (1) DE69520041T2 (de)
ES (1) ES2156603T3 (de)
FR (1) FR2722098B1 (de)
IL (1) IL114276A0 (de)
WO (1) WO1996001117A1 (de)
ZA (1) ZA954881B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1112072A2 (de) * 1998-08-31 2001-07-04 Sentron Medical, Inc. Methimazole derivate und tautomerische cyclische thione zur behandlung von autoimmunkrankheiten
EP1206937B1 (de) * 1999-07-16 2008-01-23 Shoei Co., Ltd. Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6468989B1 (en) 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
WO2002094179A2 (en) * 2001-05-23 2002-11-28 J.B. Chemicals & Pharmaceuticals Ltd. Novel topical microbicidal compositions
US6881726B2 (en) 2001-12-24 2005-04-19 Dow Pharmaceutical Sciences Aqueous compositions containing metronidazole
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
US7060729B2 (en) * 2002-09-05 2006-06-13 Reza Babapour Composition and method for treating skin
RS20050557A (en) 2003-01-24 2007-09-21 Connetics Australia Pty Ltd., Clindamycin phosphate foam
US8313775B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
JP2006528189A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質産物、その使用法および製剤
WO2005009364A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1653925A1 (de) 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robustes pellet
AU2004264356B2 (en) 2003-08-12 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP5686494B2 (ja) 2003-08-29 2015-03-18 シオノギ インコーポレイテッド 抗生物質製剤、その使用法及び作成方法
CA2538064C (en) 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
US7205006B2 (en) * 2003-09-25 2007-04-17 Prime Pharmaceutical Corporation Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
FR2866569B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter des pathologies liees au recepteur de type b de l'interleukine 8 et/ou au recepteur de type 1 de pacap
FR2866570B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter une inflammation cutanee
FR2887149B1 (fr) 2005-06-17 2007-08-03 Galderma Sa Procede de solubilisation du metronidazole
US8715727B2 (en) 2004-07-02 2014-05-06 Shionogi Inc. Tablet for pulsed delivery
EP1671623A1 (de) * 2004-10-01 2006-06-21 Giuseppe Vrespa Zusammensetzung zur antibakteriellen und entzündungshemmenden Behandlung der Mundhöhle
CN1297563C (zh) * 2004-10-14 2007-01-31 盛四龙 克林霉素甲硝唑阴道栓
FR2882552B1 (fr) * 2005-02-25 2008-12-26 Galderma Sa Gel aqueux de haute stabilite a base de metronidazole et procedes pour leur preparation
CA2612408A1 (en) * 2005-06-15 2006-12-28 Apollo Pharmaceutical, Inc. Pharmaceutical composition comprising a mahonia aquifolium extract for the treatment of psoriasis
MXPA05008571A (es) * 2005-08-12 2007-02-12 Leopoldo Espinosa Abdala Formulaciones farmaceuticas solidas, semisolidas, en suspension, en solucion, en emulsion o en jarabe conteniendo clindamicina y uno o mas de los miembros de la familia de los azoles.
CN100370994C (zh) * 2005-08-24 2008-02-27 王卫阳 克林霉素甲硝唑软膏及其制备方法
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2010047831A1 (en) * 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
US20100273756A1 (en) * 2009-04-27 2010-10-28 Reza Babapour Adjunctive formulation and methods for palliation of fine wrinkles, mottled hyperpigmentation, tactile roughness of facial skin and related disorders
CN103006681B (zh) * 2012-12-04 2014-07-09 哈尔滨乐泰药业有限公司 治疗痤疮的复方乳膏及其制备方法
WO2016069952A1 (en) * 2014-10-31 2016-05-06 Sreedhar Rao Rayudu Anti-acne composition and methods of use
US11160867B2 (en) * 2017-05-11 2021-11-02 Auburn University Anti-protozoal compounds and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018918A (en) * 1975-05-20 1977-04-19 The Upjohn Company Topical clindamycin preparations
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
ATE67667T1 (de) * 1987-03-20 1991-10-15 Curatek Pharmaceuticals Neue topische metronidazol-formulierungen.
US4957918A (en) * 1988-06-09 1990-09-18 Leonard Bloom Topical treatment of blepharitis

Also Published As

Publication number Publication date
EP0768884A1 (de) 1997-04-23
DE69520041T2 (de) 2001-06-21
JP3006888B2 (ja) 2000-02-07
FR2722098A1 (fr) 1996-01-12
AU2798495A (en) 1996-01-25
JPH10500700A (ja) 1998-01-20
CA2191129C (fr) 2001-06-19
ZA954881B (en) 1996-01-30
IL114276A0 (en) 1995-10-31
WO1996001117A1 (fr) 1996-01-18
FR2722098B1 (fr) 1996-08-23
US5849776A (en) 1998-12-15
CA2191129A1 (fr) 1996-01-18
ES2156603T3 (es) 2001-07-01
EP0768884B1 (de) 2001-01-31

Similar Documents

Publication Publication Date Title
DE69520041D1 (de) Arzneimittel auf der basis von einer synergistischen mischung von metronidazol und clinamicin
ATE238801T1 (de) Arzneimittel zur transdermalen verabreichung von einem östrogen oder progestin oder einer mischung davon
DE69429821D1 (de) Farnesyl-derivate und diese enthaltende arzneimittel
FI961951A0 (fi) Piperidiinit, pyrrolidiinit ja heksahydro-1H-atsepiinit edistävät kasvuhormonin vapautumista
DE69429089D1 (de) Gehärtete und feuerhemmende holzprodukte
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
DE68907769D1 (de) Vorrichtung zum schutz und zur verabreichung von fluessigkeitsempfindlichen arzneimitteln.
DE69631531D1 (de) Katheter zur verabreidung von arzneien
FI946050A0 (fi) Vaermeisolerande pappersbehaollare och foerfarande foer framstaellning av den
FI952266A0 (fi) Indentyyliyhdisteitä ja katalyyttiaineosia olefiinien polymeroimiseksi
DE69427814D1 (de) Kupplungsprodukt zwischen einer aminosaeure und histamin
EE9600139A (et) Farmatseutilised preparaadid ja ravimid endoteelsete düsfunktsioonide vältimiseks ja raviks
DE4390357T1 (de) Auf Wahrnehmungsfähigkeit basierender kindergesicherter und originalitätsgesicherter Verschluß
DE69528165D1 (de) Transdermal verabreichbare grundlage und daraus hergestelltes transdermal verabreichbares arzneimittel
DE59410107D1 (de) Chinoxaline und arzneimittel daraus
DE69324393D1 (de) Mittel auf Basis von Antiseptiken und ihre Verwendungen
FI944958A (fi) Polymeerituotteet ja -materiaalit
NO934552L (no) Fremgangsmåte for beskyttelse og reparasjon av plast- og plastkomposittmaterialer
FI950029A0 (fi) Uusia analgeettisia ja nootrooppisia lääkeaineita
FI950575A (fi) 3- ja 5-substituoidut 1,2,3,4-oksatriatsoli-5-imiiniyhdisteet, niiden valmistusmenetelmä, mainittuja yhdisteitä sisältävä farmaseuttinen valmiste ja mainittujen yhdisteiden käyttö lääkkeiden valmistukseen
DE69310454D1 (de) Verpackungsverfahren und entsprechende Verpackung
FI970713A (fi) Menetelmiä hampaiden ja suun luuston kunnon ylläpitämiseksi
DE69431154D1 (de) Arzneimittel zur topischen Anwendung
KR940009403U (ko) 재사용 가능한 기저귀 제품
FI971378A (fi) Menetelmiä ja välituotteita 3-aminobentso(b)-atsepinonien valmistusta varten

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: GALDERMA RESEARCH & DEVELOPMENT, BIOT, FR